Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

pBFS Guided High-dose rTMS Therapy for Treatment-Resistant Depression

NCT: NCT05842291 · SUSPENDED

NCT IDNCT05842291

StatusSUSPENDED

Start Date2023-06-19

Completion2026-07-30

Brief Summary

We aim to evaluate the safety and efficacy of pBFS-guided high-dose rTMS therapy with short inter-session interval for patients with treatment-resistant depression

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑